NIHR Evaluation, Trials and Studies News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Progesterone supplements do not improve outcomes for women with recurrent miscarriages
The findings from a five-year trial funded by the HTA programme has published in The New England Journal of Medicine. The progesterone in miscarriage treatment (PROMISE) trial conducted in 45 hospitals in the UK and the Netherlands, involved 826 women with unexplained recurrent miscarriage. The findings showed that those who received progesterone treatment in early... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - December 2, 2015 Category: American Health Source Type: news

Join the NIHR Public Health Research Programme Advisory Board
Do you want to influence the direction of research for public health? There are currently a number of vacancies on the Programme Advisory Board (PAB). We are seeking experienced senior public health decision makers to help us identify and commission new research. The NIHR PHR Programme funds research to evaluate any non-NHS intervention with the... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - December 1, 2015 Category: American Health Source Type: news

New study looks at support to improve health and well-being for those under community supervision
People receiving community supervision (from Community Rehabilitation Companies or the National Probation Service) often have greater healthcare needs compared with the rest of the population, and experience greater problems accessing that healthcare. This is particularly true for those who have recently been released from prison.A pilot study, funded by the NIHR PHR Programme, will assess... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 27, 2015 Category: American Health Source Type: news

No benefit found for use of probiotic Bifidobacterium breve in very preterm children to prevent death, late-onset sepsis, or necrotising enterocolitis
The results of a randomised controlled trial, published today in The Lancet, show that, despite being safe to administer, there is no benefit in using the probiotic Bifidobacterium breve (BBG-001) to prevent late-onset sepsis or necrotising enterocolitis in very preterm children. This new study, funded by the NIHR HTA Programme contradicts previous work showing potential... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 26, 2015 Category: American Health Source Type: news

New study could save lives of people suffering respiratory failure
One of the largest clinical trials in the world, to date, involving patients with respiratory failure has been funded by the National Institute for Health Research (NIHR). The trial will evaluate a potentially revolutionary new technology that could saves thousands of lives in Intensive Care Units around the world.Covering 1,120 critically ill patients in 40... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 26, 2015 Category: American Health Source Type: news

New HTA Clinical Evaluation and Trials board Deputy Chair appointed
The NIHR HTA Programme is pleased to announce that Professor Julia Brown, Director of the Clinical Trials Unit at the University of Leeds has been appointed as Deputy Chair of the HTA Clinical Evaluation and Trials board.Professor Brown spent a number of years in the NHS and Industry before joining the Clinical Trials Unit at... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 24, 2015 Category: American Health Source Type: news

The value of information
Given the wealth of information that we gather through the activities of the NIHR, it is often useful to think of new ways to encourage people to submit information and make their views known.The launch of the recent Mental Health Matters campaign demonstrated an innovative way of inviting contributions from experts in the field of... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 23, 2015 Category: American Health Source Type: news

Probiotics research for elderly care patients
Infections are the most common reason for care home residents to be hospitalised, and previous research shows care home residents are the biggest user group for antibiotics, which puts them at significant risk of developing antibiotic drug resistance. This resistance can spread to hospitals and the community – reducing the effectiveness of these important drugs... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 23, 2015 Category: American Health Source Type: news

New Alzheimer’s disease drug trial opens across Scotland
A new trial, funded by the Efficacy and Mechanism Evaluation (EME) Programme is investigating if a drug normally used to treat high blood pressure (hypertension) has additional properties that could slow down the progression of Alzheimer’s disease in people with and without hypertension. Led by academics from the Universities of Bristol, Cambridge, Queen’s University Belfast,... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 18, 2015 Category: American Health Source Type: news

NIHR invests £15 million in the fight against superbugs
Drug resistant infections present a major threat to the future of healthcare and could result in 10 million avoidable deaths in the world every year by 2050, from antibiotic resistant infections, such as MRSA, sepsis and multi-drug-resistant Mycobacterium tuberculosis. The Department of Health, in its UK Antimicrobial Resistance Strategy, has called for more research into... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 18, 2015 Category: American Health Source Type: news

Research finds busway encourages people to become more active on the commute
Research funded by the NIHR’s PHR Programme has found that the presence of the Cambridgeshire Guided Busway noticeably increases the time local commuters spent cycling.The study followed 469 commuters and assessed changes to their activity patterns before and after the opening of the Cambridgeshire Guided Busway. The latest results, published today in the American Journal... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 13, 2015 Category: American Health Source Type: news

Computer assisted CBT provides little or no benefits for depression
Computer assisted cognitive behavioural therapy is likely to be ineffective in the treatment of depression because of low patient adherence and engagement, suggests the largest study of its kind published in The BMJ.Cognitive behavioural therapy (CBT) is considered an effective "talking treatment" for depression, but is not always immediately available in the NHS. Computerised CBT... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 13, 2015 Category: American Health Source Type: news

Next submission dates for demonstrating the benefits of NIHR funded research
The next NIHR Researchfish submission period for the NIHR is 15 February – 23 March 2016. The information provided through Researchfish feeds into reports and decision-making processes such as the Government’s comprehensive spending review. The submission period has moved to align with other funders such as the research councils and medical research charities. All... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 12, 2015 Category: American Health Source Type: news

No conclusive evidence Omega 3 supplements are effective in treating major depressive disorders
A Cochrane review published today in the Cochrane Library concludes that there is limited evidence that taking an Omega 3 fatty acid supplement is effective in treating major depressive disorders.Omega 3 fatty acids have been promoted globally as a supplement to help maintain good health and is among a range of other supplements, vitamins and... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 4, 2015 Category: American Health Source Type: news

New HTA funding board Chair appointed
We are pleased to announce that Professor Deborah Ashby has been successfully been appointed as Chair of the Commissioning Board for the NIHR HTA Programme. She will also be taking on the role of Deputy Programme Director to Professor Hywel Williams from January 2016. Professor Ashby is a widely published and respected Chartered Statistician and... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - November 4, 2015 Category: American Health Source Type: news